Vol 5 (2020): Continuous Publishing
Case report
Published online: 2020-11-25

open access

Page views 526
Article views/downloads 521
Get Citation

Connect on Social Media

Connect on Social Media

Progressive bilateral ocular ischemic syndrome despite previously performed carotid endarterectomy

Marta Świerczyńska12, Lech Sedlak12, Mariola Dorecka12
Ophthalmol J 2020;5:114-119.


The ocular ischemic syndrome (OIS) is a rare condition with vision-threatening potentials. It is characterized by chronic ischemia of the anterior and/or posterior segment of the eye primarily caused by severe carotid artery occlusive diseases. In this article, we present a case of a 67-year-old male patient presented with the gradual diminution of vision in the right eye for 6 months. The patient had undergone a right internal carotid artery (ICA) endarterectomy (CEA) twice before. On the day of admission, intraocular pressure (IOP) was 34 mm Hg in the right eye (RE) and 20 mm Hg in the left eye (LE). On anterior segment examination, neovascularization of iris in the right eye was noted. On fundoscopy dilated retinal veins, attenuated retinal arteries, blot hemorrhages, cotton wool spots and microaneurysms were present. The patient underwent the appropriate investigations including computed tomography angiography (CTA) of carotid arteries, fundus fluorescence angiography (FFA) and Doppler ultrasound (DUS) of ophthalmic and central retinal arteries, which were all consistent with a diagnosis of bilateral OIS. Intraocular pressure was pharmacologically reduced and stabilized. Subsequently, panretinal photocoagulation (PRP) of peripheral capillary nonperfusion areas was performed in both eyes.

Article available in PDF format

View PDF Download PDF file


  1. Mendrinos E, Machinis TG, Pournaras CJ. Ocular ischemic syndrome. Surv Ophthalmol. 2010; 55(1): 2–34.
  2. Terelak-Borys B, Skonieczna K, Grabska-Liberek I. Ocular ischemic syndrome - a systematic review. Med Sci Monit. 2012; 18(8): RA138–RA144.
  3. Sharma S, Brown GC. Ocular Ischemic Syndrome. In: Ryan SJ, Hinton DR, Schachat AP. ed. Retina. Elsevier, New York 2006: 1491–1502.
  4. Luo J, Yan Z, Jia Yu, et al. Clinical Analysis of 42 Cases of Ocular Ischemic Syndrome. J Ophthalmol. 2018; 2018: 2606147.
  5. Hong IH, Ahn JK, Chang S, et al. Diagnostic efficacy of total homocysteine and C-reactive protein for ocular ischemic syndrome. Eye (Lond). 2011; 25(12): 1650–1654.
  6. Wang H, Wang Y, Li H. Multimodality Imaging Assessment of Ocular Ischemic Syndrome. J Ophthalmol. 2017; 2017: 4169135.
  7. Mizener J, Podhajsky P, Hayreh S. Ocular Ischemic Syndrome. Ophthalmology. 1997; 104(5): 859–864.
  8. Peter J, David S, Danda D, et al. Ocular manifestations of Takayasu arteritis: a cross-sectional study. Retina. 2011; 31(6): 1170–1178.
  9. Tang Y, Luo D, Peng W, et al. Ocular ischemic syndrome secondary to carotid artery occlusion as a late complication of radiotherapy of nasopharyngeal carcinoma. J Neuroophthalmol. 2010; 30(4): 315–320.
  10. Huang ZL, Lin KH, Lee YC, et al. Acute vision loss after intravitreal injection of bevacizumab (avastin) associated with ocular ischemic syndrome. Ophthalmologica. 2010; 224(2): 86–89.
  11. Chen CS, Miller NR. Ocular ischemic syndrome: review of clinical presentations, etiology, investigation, and management. Compr Ophthalmol Update. 2007; 8(1): 17–28.
  12. Kang HM, Choi JH, Koh HJ, et al. Significant changes of the choroid in patients with ocular ischemic syndrome and symptomatic carotid artery stenosis. PLoS One. 2019; 14(10): e0224210.
  13. Wierzbowska J, Robaszkiewicz J, Figurska M, et al. Future possibilities in glaucoma therapy. Med Sci Monit. 2010; 16(11): RA252–RA259.
  14. Choi EY, Lee SC, Kim M. Optical Coherence Tomography Angiography Before and After Bevacizumab Injection in Ocular Ischemic Syndrome. Retina. 2018; 38(3): e23–e25.
  15. Dzierwa K, Pieniazek P, Musialek P, et al. Treatment strategies in severe symptomatic carotid and coronary artery disease. Med Sci Monit. 2011; 17(8): RA191–RA197.
  16. Kawaguchi S, Iida JI, Uchiyama Y. Ocular Circulation and Chronic Ocular Ischemic Syndrome before and after Carotid Artery Revascularization Surgery. J Ophthalmol. 2012; 2012: 350475.
  17. Tripathy K, Mazumdar S. Recurrent retinal and choroidal ischemia in a case of ocular ischemic syndrome. Ther Adv Ophthalmol. 2019; 11: 2515841419848926.
  18. Fintelmann RE, Rosenwasser RH, Jabbour P, et al. An old problem, a new solution. Surv Ophthalmol. 2010; 55(1): 85–88.
  19. Klijn CJM, Kappelle LJ, van Schooneveld MJ, et al. Venous stasis retinopathy in symptomatic carotid artery occlusion: prevalence, cause, and outcome. Stroke. 2002; 33(3): 695–701.
  20. Hayreh SS, Zimmerman MB. Ocular arterial occlusive disorders and carotid artery disease. Ophthalmol Retina. 2017; 1(1): 12–18.
  21. Mills RP. Anterior segment ischemia secondary to carotid occlusive disease. J Clin Neuroophthalmol . 1989; 9(3): 200–204.